Title : A prospective phase II study: high-dose pemetrexed as second-line chemotherapy in small-cell lung cancer.

Pub. Date : 2009 Jan

PMID : 18538889






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 PURPOSE: To investigate the efficacy and tolerability of high-dose pemetrexed as second-line chemotherapy in small cell lung cancer (SCLC). Pemetrexed SCLC1 Homo sapiens
2 CONCLUSION: High-dose pemetrexed monotherapy to patients with recurrent SCLC yielded moderate toxicity, but limited treatment efficacy. Pemetrexed SCLC1 Homo sapiens